Bafna Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on May 20, 2013, to consider and approve Audited Financial Results of the Company for the year ended March 31, 2013 on Standalone and Consolidated basis and to recommend payment of dividend, if any.
Further, the board to consider re-appointment of Bafna Mahaveer Chand as Chairman and Managing Director and Paras Bafna as Whole Time Director.
The above information is a part of company’s filings submitted to BSE.
